CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease.

Lorenzo Barba,Samir Abu-Rumeileh,Steffen Halbgebauer,Giovanni Bellomo,Federico Paolini Paoletti,Lorenzo Gaetani,Patrick Oeckl,Petra Steinacker,Federico Massa,Lucilla Parnetti,Markus Otto

Neurology（2023）

引用 3|浏览5

暂无评分

摘要

This study provides Class II evidence that CSF levels of β-synuclein, α-synuclein, SNAP-25, neurogranin and NfL are higher in patients with AD than in patients with LBD.

查看译文

关键词

biomarkers,disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要